Treatment of Gastroesophageal Junction Carcinoma
This video reviews first- and second-line treatment options for patients with carcinoma of the gastroesophageal junction.
In this video, Ian Chau, MD, of Royal Marsden Hospital in London, reviews first- and second-line treatment options for patients with carcinoma of the gastroesophageal junction.
In the first-line setting, different standards for treatment duration exist around the world, including the idea of rechallenging with the same chemotherapy if a patient achieves stable disease.
In the second-line setting, Chau discusses the use of chemotherapy and ramucirumab.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
![“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F9b290688648a249e516474c175a3c06309426d15-2950x1568.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.")
Related Content
